Coherent unveils Osprey femtosecond laser for medical applications

Published 23/06/2025, 21:50
Coherent unveils Osprey femtosecond laser for medical applications

NEW YORK - Coherent Corp. (NYSE:COHR), which generated $5.6 billion in revenue over the last twelve months with 21.7% growth, introduced its new femtosecond laser called Osprey, designed for applications in optogenetics, microsurgery, and medical device manufacturing, according to a company press release issued Monday. According to InvestingPro data, the company maintains strong liquidity with a healthy current ratio of 2.47, positioning it well for product expansion.

The laser delivers pulse energies up to 5 µJ with sub-350 femtosecond pulse widths in a compact form factor. The company states the system features high beam quality and pointing stability while maintaining power efficiency.

Osprey utilizes a fiber-based architecture that operates with less than 150 W power draw on a standard 24 V DC supply. The system includes integrated AOM and wide dispersion pre-compensation for operation across complex optical paths.

"We designed Osprey to deliver clean, stable, high-quality femtosecond pulses with minimal power draw and maximum system stability," said Dr. Chris Dorman, Executive Vice President of Coherent’s Lasers Business Group.

The new laser joins Coherent’s existing ultrafast portfolio, which includes the Monaco and Axon series that are optimized for different applications in bioimaging and microsurgery.

The company reports that qualification units of Osprey are currently available, with volume production scheduled to begin in January 2026. Coherent plans to showcase the laser at LASER World of Photonics Munich 2025.

The introduction comes as femtosecond lasers increasingly transition from research settings into clinical and industrial environments where reliability, beam quality, and cost efficiency have become critical factors, according to the release.

In other recent news, Coherent Corp. introduced a new line of disposable surgical fiber assemblies designed for precision medical applications, highlighting their capability to transmit high-power laser energy for various surgical procedures. Additionally, Coherent unveiled the LEAP 600C, a 600-watt excimer laser for high-temperature superconducting tapes, which is expected to enter production in late 2025. The company also launched an 18W laser diode aimed at enhancing micromachining and semiconductor processing applications, emphasizing its high optical output power and efficiency. Furthermore, Coherent released a diamond-loaded silicon carbide composite for AI datacenters, claiming it offers double the thermal performance of copper. In terms of financial outlook, JPMorgan raised its price target for Coherent to $100, maintaining an Overweight rating, citing confidence in the company’s projected growth and margin improvements. JPMorgan’s revised estimates include a 10% revenue growth for fiscal years 2026 and 2027, with gross margins expected to reach 39% and 40% respectively. The research firm highlighted Coherent’s broad-based portfolio as a key factor in its positive outlook. These developments reflect Coherent’s ongoing innovation in photonics and materials technology.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.